Professor Anant Madabhushi (PI) and Ibris Inc., a start-up company founded by Professor Madabhushi and Dr. James Monaco in 2010, has been awarded a 1 year Phase 1 NIH SBIR award from the National Institute for Biomedical Imaging and Bioengineering for the project entitled "Decision Support System for Predicting outcome of ER+ breast cancers". The goal of this project is to develop image based classifiers of disease aggressiveness based of quantitative analysis of digitized breast cancer biopsy specimens.Dr. Scott Doyle, former graduate student of Professor Madabhushi`s and BME alum, will serve as the PI from Ibris Inc. Dr. Shridar Ganesan will serve as the clinical PI from UMDNJ. Ibris Inc has been supported by the Center of Innovation, Ventures, and Emerging Technology (CIVET)